The European Medicines Agency provides an interactive map with data from the information system for clinical trials. This is ...

The EMA warns of products being sold as dendritic cell therapies with little evidence, but high health risks, in the European ...

From funding challenges to what changes in joint drug procurement: Here’s what you need to know about the new rules aimed at ...

Eli Lilly (NYSE:LLY) recently announced several significant events, including promising trial results for baricitinib in ...

The drug shortages are the result of manufacturing problems, increased demand, and other issues. View on euronews ...

At its March meeting, the European Medicines Agency’s management board adopted the EMA’s annual report for 2024. This ...

Otsuka Pharmaceutical Europe and Lundbeck have announced that the European Commission has approved Rxulti (brexpiprazole) for ...